ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Stop MS: Buena Vista’s Chris Martin set to try cutting-edge stem cell program – Chaffee County Times

Continue reading

2017-05-11 Michael Zand NEWS

Hematologic Malignancies at the Cutting Edge of Immunotherapy, Expert Says – Targeted Oncology


Chaffee County Times

Stop MS: Buena Vista’s Chris Martin set to try cutting-edge stem cell program
Chaffee County Times
Diagnosed with multiple sclerosis almost 11 years ago, Martin is set to begin his first round of experimental umbilical stem cell therapy from Denver Regenerative Medicine next month. Martin experienced his first symptoms in 2006, while running the …

Continue reading

2017-05-11 Michael Zand NEWS

Crispr Makes It Clear: The US Needs a Biology Strategy, and Fast – WIRED

WIREDCrispr Makes It Clear: The US Needs a Biology Strategy, and FastWIREDBiology has emerged as one of the most important technology platforms of the 21st century. With the arrival of the gene-editing technology Crispr, biology will soon converge with… Continue reading

2017-05-11 Michael Zand NEWS

CRISPR Therapeutics Reports Financial Results for the Three Months Ended March 31, 2017 and Provides Business … – Nasdaq

CRISPR Therapeutics Reports Financial Results for the Three Months Ended March 31, 2017 and Provides Business …NasdaqBASEL, Switzerland and CAMBRIDGE, Mass., May 11, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics, (NASDAQ:CRSP), a biopharmaceutical com… Continue reading

2017-05-11 Michael Zand NEWS

CRISPR Therapeutics Reports Financial Results for the Three Months Ended March 31, 2017 and Provides Business … – GlobeNewswire (press release)

CRISPR Therapeutics Reports Financial Results for the Three Months Ended March 31, 2017 and Provides Business …GlobeNewswire (press release)BASEL, Switzerland and CAMBRIDGE, Mass., May 11, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics, (NASDAQ:CRSP), … Continue reading

2017-05-11 Michael Zand NEWS

uniQure (QURE) Presents Data on Successful Readministration of Gene Therapy in Non-Human Primates – StreetInsider.com

Hematologic Malignancies at the Cutting Edge of Immunotherapy, Expert Says
Targeted Oncology
“I think that we have always been ahead of the curve—as far as moving new treatments forward—and with respect to immunotherapy, we are also at the cutting edge,” said Leonard, a professor of medicine at Weill Cornell Medicine/NewYork-Presbyterian …

Continue reading

2017-05-11 Michael Zand NEWS

uniQure Announces Successful Readministration of Gene Therapy in Non-Human Primates – Nasdaq

uniQure Announces Successful Readministration of Gene Therapy in Non-Human PrimatesNasdaqLEXINGTON, Mass. and AMSTERDAM, the Netherlands, May 11, 2017 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformati… Continue reading

2017-05-11 Michael Zand NEWS

uniQure Announces Successful Readministration of Gene Therapy in Non-Human Primates – Nasdaq

uniQure Announces Successful Readministration of Gene Therapy in Non-Human PrimatesNasdaqLEXINGTON, Mass. and AMSTERDAM, the Netherlands, May 11, 2017 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformati… Continue reading

2017-05-11 Michael Zand NEWS
  • 1
  • …
  • 1,740
  • 1,741
  • 1,742
  • 1,743
  • 1,744
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

uniQure (QURE) Presents Data on Successful Readministration of Gene Therapy in Non-Human Primates
StreetInsider.com
uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today presented data on successful repeated hepatic gene delivery with uniQure’s AAV5 vector following a …

and more »